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Abstract
Background: Post-menopausal women may be at particular risk of developing cardiovascular 
disease due to metabolic changes occurring at menopause. The present study aimed to assess  
the 10-year cardiovascular risk (CVR) among a group of post-menopausal women and to de-
termine associated factors.
Methods: This was a cross-sectional study conducted among post-menopausal women in 
Yaoundé, Cameroon. CVR was calculated using the Framingham risk score.
Results: We enrolled 108 women, their ages ranging from 45 to 80 years, with a mean of 56.4 ±  
± 6.9 years. CVR ranged between 1.2% and greater than 30% with a mean of 13.4 ± 8.7%. 
Forty-three (39.8%) participants had a low CVR (< 10%), 39 (36.1%) women had a moderate 
CVR (10-20%), and 21 (24.1%) women had a high CVR (> 20%). Low-density lipoproteins 
cholesterol (LDL-C; b = 3.27, p = 0.004), fasting plasma glucose (b = 5.40, p = 0.015), and 
diastolic blood pressure (DBP; b = 3.49, p < 0.0001) were independently associated with 
CVR. Women not married (i.e. single, divorced or widowed) (adjusted odds ratio [aOR] 4.66, 
p = 0.002), those with high titers of LDL-C (≥ 1.6 g/L; aOR 5.07, p = 0.001), and those with 
elevated DBP (≥ 90 mm Hg; aOR 8.10, p < 0.0001) presented an increased likelihood to be 
at an advanced level of CVR.
Conclusions: A significant number of post-menopausal women are at considerable risk of 
cardiovascular events in our setting. Therefore, they should be educated to adopt healthy life-
styles for substantial reduction in their CVR. (Cardiol J 2016; 23, 2: 123–131)
Key words: post-menopausal women, cardiovascular disease, cardiovascular 
risk, Cameroon, Sub-Saharan Africa
123www.cardiologyjournal.org
ORIGINAL ARTICLE
Cardiology Journal 
2016, Vol. 23, No. 2, 123–131
DOI: 10.5603/CJ.a2015.0056
Copyright © 2016 Via Medica
ISSN 1897–5593
Introduction
Cardiovascular disease (CVD) is by far the 
leading cause of death in most developed countries 
and is rapidly becoming the leading cause of death 
in the world [1]. Indeed, the World Health Organi-
zation (WHO) estimates that annual global mortal-
ity due to CVD is projected to increase from 17.5 
million in 2012 to 22.2 million by 2030, with almost 
80% occurring in developing countries [2]. The 
high cardiovascular mortality in these countries is 
fueled by very low rates of awareness, treatment, 
and control of cardiovascular risk factors such as 
hypertension, diabetes and dyslipidemia alongside 
the increase in life expectancy [1].
Menopause, which is the cessation of monthly 
menstrual cycles resulting from the loss of ovarian 
function and a decrease in estrogen production, is 
widely recognized as a risk factor for CVD [3–6]. 
In fact, while cardiovascular events (CVE) are 
a rare occurrence in pre-menopausal women, their 
incidence increases drastically after menopause, 
and one related clue factor can be attributed to the 
significantly reduced production of estrogen along 
with concomitant loss of its direct and indirect 
cardioprotective effects [3, 7]. The prevalence of 
myocardial infarction in women with normal levels of 
estrogens has been shown to be very low (1% to 7% 
per 100,000) and 3–5 times lower than in men [8].
Actually, endogenous estrogens exert a protec-
tive effect against atherogenesis and consequential 
CVD [9]. Low plasma estrogen levels may explain 
some of the unfavorable lipid and carbohydrate 
metabolism changes rapidly occurring during 
menopausal transition and soon after menopause, 
which can result in metabolic disorders and the 
metabolic syndrome, increasing thereby the likeli-
hood of diabetes and CVD [10–12].
Post-menopausal women are at higher risk of 
CVD. CVD is indeed considered to be the primary 
cause of mortality in these women [13]. In this regard, 
management of the peri-menopausal woman should 
not rely on the exclusive responsibility of the gynecolo-
gist. An interdisciplinary approach should be adopted 
by the gynecologist not just evaluating vasomotor and 
urogenital symptoms, but also assessing the patient for 
cardiovascular risk (CVR), and cardiovascular physi-
cian helping in the management and close follow-up 
of women at increased risk of CVD [7].
Accurate assessment of CVR in current medi-
cal practice is essential for clinical decision making, 
because the benefits, risks, and costs of alternative 
management strategies must be weighed to choose 
the best attitude or treatment for each patient [14]. 
However, very little is known about CVR in meno-
pausal women from Sub-Saharan African (SSA) 
countries. The purpose of the present study was 
therefore to assess the 10-year risk of CVE among 
a group of SSA post-menopausal women and to 
determine associated factors.
Methods
Ethics statement
Prior to recruitment of participants, an institu-
tional authorization was obtained from authorities of 
the Yaoundé University Teaching Hospital, and an 
ethical clearance was granted by the Ethical Review 
Board of the Faculty of Medicine and Biomedical 
Sciences of the University of Yaoundé I, Cameroon. 
All the procedures used in the present study were 
in keeping with the current revision of the Helsinki 
Declaration. Respondents were all informed of the 
various aspects of the study, and were enrolled only 
after they had provided a signed consent form.
Study design and participants
This was a cross-sectional study conducted in 
January 2015 at the Yaoundé University Teaching 
Hospital, Cameroon. We enrolled post-menopausal 
women whose last menses dated back to at least 
1 year, with no previous history of CVE, in apparent 
good health, who were visiting the study site for 
various reasons, and who volunteered to participate 
in the survey. A convenient sample of 100 women 
was set, and women fulfilling our inclusion criteria 
were recruited during the study period.
Data collection
A structured pre-tested questionnaire served 
for collection of data which included socio-demo-
graphic characteristics (age, region of origin, re-
ligion, profession, marital status), medical history 
(past medical events, family history of diabetes, 
hypertension or other relevant disease), and life-
style habits (physical exercise, smoking (defined as 
having smoked any cigarettes in the past month), 
consumption of alcohol, lipids and butter specifi-
cally, carbohydrates, and consumption of fruits and 
vegetables among others). A physical examim-
tion was subsequently undertaken during which 
blood pressure and anthropometric variables were 
measured. These latter parameters included body 
weight (to the nearest kilogram), and height (to the 
nearest centimeter). Body mass index (BMI) was 
then derived as weight [kg] / height × height [m]. 
At the end of this stage, participants were given 
an appointment for blood collection.
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Blood sampling and biochemical  
measurements
Fasting blood samples were collected after 
a 12-hour overnight fasting, and processed for bio-
chemical determinations including fasting plasma 
glucose (FPG), total cholesterol (TC), triglycerides 
(TG), high-density lipoprotein cholesterol (HDL-C) 
and uric acid. Low-density lipoprotein choles-
terol (LDL-C) was then derived using Friedwald 
formula [15].
Cardiovascular risk assessment  
and stratification
The 10-year CVR was assessed using the 
Framingham risk score (FRS) [16] and was elec-
tronically calculated after entering the required 
parameters on this web page: https://www.cvdrisk-
checksecure.com/FraminghamRiskScore.aspx/. 
The FRS predicts the 10-year risk of developing 
a coronary event (composite of myocardial in-
farction and coronary death), and is considered 
a standard and generally acceptable approach to 
risk prediction [17]. Participants were afterwards 
grouped into 3 classes, given they presented 
a low CVR (score < 10%), a moderate CVR (score 
10–20%) or a high CVR (score > 20%) [16].
Statistical methods
Data were coded, entered and analyzed us-
ing SPSS version 20.0 (IBM SPSS Inc., Chicago, 
Illinois, USA). Results are presented as count 
(proportion) for qualitative variables and mean 
± standard deviation (SD) for quantitative ones. 
The Student’s t test served for comparison of quan-
titative variables. The Pearson correlation test and 
linear regression models were used to seek linear 
relation between quantitative variables. Odds ratios 
(OR) with 95% confidence intervals (CI) were used 
to investigate the influence of categorical variables 
on CVR, and were assessed by both univariable 
and multivariable logistic regression analyses 
while adjusting for confounders. All variables with 
a p value < 0.20 were introduced in the multivari-
able models. A p value < 0.05 was used to charac-
terize statistically significant results.
Results
Socio-demographic background, medical 
history and lifestyle habits
On the whole, we enrolled 108 women, their 
ages ranging from 45 to 80 years with a mean of 
56.4 ± 6.9 years. Most of women (67.5%) origi-
nated from the West region of Cameroon (Table 1). 
Fifty four point six percent of women were catholic 
by faith, 60.2% were housewives, and 66.5% were 
married (Table 1).
Table 1. Socio-demographic profile, medical his-
tory and lifestyle habits of the study population 
(n = 108).
Variable Number (%)
Age:
£ 60 years old 85 (78.7%)
> 60 years old 23 (21.3%)
Religion:
Catholic 59 (54.6%)
Protestant 48 (44.6%)
Pentecost 1 (0.9%)
Region of origin:
Center 23 (21.3%)
West 71 (65.7
Littoral 7 (6.5%)
South-West 1 (0.9%)
North-West 1 (0.9%)
North 3 (2.8%)
South 2 (1.9%)
Profession:
Housewife 65 (60.2%)
Civil servant 14 (13.0%)
Retired 8 (7.4%)
Trader 21 (19.4%)
Marital status: 
Single 9 (8.3%)
Married 72 (66.7%)
Widowed 25 (23.1%)
Divorced 2 (1.9%)
Known diabetes patient: Yes 16 (14.8%)
Known hypertensive patient: Yes 37 (34.3%)
Family history of diabetes or  
hypertension: Yes
54 (50.0%)
Practicing a physical activity: Yes 56 (51.9%)
Type of physical activity practiced:
Walking 55 (98.2%)
Riding a bicycle 1 (1.8%)
Smoking: Yes 5 (4.6%)
Taking alcohol occasionally: Yes 77 (71.3%)
Regular consumption of  
carbohydrates: Yes
72 (66.7%)
Regular consumption of butter: Yes 49 (45.4%)
Regular consumption of lipids: Yes 103 (95.4%)
Used to eat fruits and vegetables: Yes 106 (98.1%)
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had a high FPG level (≥ 1.26 g/L). We recorded 
73 (67.6%) cases of elevated levels of TC (≥ 2 g/L), 
9 (8.3%) cases of high TG values (≥ 1.6 g/L), 
55 (50.9%) cases of high LDL-C titers (≥ 1.6 g/L), 
and 12 (11.1%) women showed low levels of 
HDL-C (£ 0.35 g/L). Forty-one (38%) women had 
hyperuricemia (≥ 60 mg/L).
Cardiovascular risk score and stratification
The 10-year risk of CVE ranged from 1.2% 
to greater than 30% with a mean of 13.4 ± 8.7%. 
The mean risk was statistically different between 
known and unknown diabetes participants (21.0 ± 
± 10.4% vs. 12.0 ± 7.7%, p < 0.0001). Likewise, 
there was a significant difference between smokers 
and non-smokers (p = 0.001), those consuming 
butter or not (p = 0.028), fruits and vegetables 
regularly or not (p = 0.002), those with high levels 
of SBP, DBP, TC, LDL-C, FPG, uric acid (all p val-
ues < 0.0001), and those with low levels of HDL-C 
(p = 0.001) when compared to their counterparts. 
On the contrary, there was no difference in mean of 
CVR with regard to regular consumption of lipids 
(p = 0.597), of carbohydrates (p = 0.171), regular 
physical activity (≥ 3 sessions per week) (p = 0.578), 
and high or low levels of TG (p = 0.214). Forty-
-three (39.8%) participants had a low risk of CVD 
(< 10%), 39 (36.1%) women had a moderate risk 
(10–20%), and 21 (24.1%) women had a high risk 
of CVD (> 20%). Besides, 90 (83.3%) participants 
had a CVR > 5%.
In univariable linear regression analysis, CVR 
was associated with LDL-C (b = 1.79, 95% CI 
0.74–2.84; p = 0.001, R2 = 0.98), TG (b = 1.94, 
95% CI 0.62–3.27; p = 0.004, R2 = 0.074), uric acid 
Table 1 also displays the medical history and 
lifestyle habits of our respondents. Sixteen (14.8%) 
participants were known diabetes patients, and 
37 (34.3%) were known hypertensive. Fifty-four 
(50%) respondents had a family history of diabetes 
or hypertension, one or both of their parents being 
concerned in 74.1% of cases. There was no known 
family history of CVE. No woman was alcoholic, 
though 77 (71.3%) used to drink alcohol occasion-
ally. Five (4.6%) women used to smoke. Fifty-six 
(51.9%) participants were currently practicing 
a physical activity: walking especially in 98.2% of 
cases. The frequency of physical exercise ranged 
from 1 to 7 sessions per week (mean: 3.2 ± 1.6), 
each session lasting from 15 to 248 min with 
a mean of 62.5 ± 42.8 min. One hundred and 
three (94.4%) women had a diet rich in lipids, with 
49 (45.4%) women who used to take butter. Seventy- 
-two (66.7%) participants were used to consuming 
carbohydrates, and 106 (98.1%) women used to 
eat fruits and vegetables, the frequency ranging 
between 1 and 7 days per week (mean: 2.9 ± 1.7).
Clinical and biochemical parameters
The mean levels of clinical and biochemical vari-
ables are depicted by Table 2. Thirty-seven (34.3%) 
women were overweight (BMI 25–29.9 kg/m2) 
and 61 (56.5%) were obese (BMI ≥ 30 kg/m2), 
among whom 9 (14.8%) women were severely obese 
(BMI ≥ 40 kg/m2). Fifty-eight (53.7%) women 
had an abnormal systolic blood pressure (SBP; 
≥ 140 mm Hg), and 38 (35.2%) women had an abnor- 
mal diastolic blood pressure (DBP; ≥ 90 mm Hg). 
Overall, 83 (76.9%) respondents had abnormally 
high blood pressure values. Six (5.6%) respondents 
Table 2. Clinical and biochemical measurements.
Variable Minimum Maximum Mean ± SD Median (IQR)
Weight [kg] 51 123 82.19 ± 14.29 80.5 (72–93.8)
Height [m] 1.50 1.79 1.61 ± 0.05 1.62 (1.58–1.65)
BMI [kg/m2] 21.20 43.60 31.56 ± 5.27 31.6 (27.93–35.0)
Systolic BP [mm Hg] 100.0 210.0 138.6 ± 23.6 140 (120–150)
Diastolic BP [mm Hg] 60.0 120.0 80.2 ± 13.0 80 (70–90)
Total cholesterol [g/L] 1.05 4.23 2.29 ± 0.63 2.29 (1.84–2.64)
LDL cholesterol [g/L] 0.22 3.54 1.59 ± 0.58 1.61 (1.22–1.89)
HDL cholesterol [g/L] 0.21 0.88 0.48 ± 0.12 0.47 (0.40–0.55)
Triglycerides [g/L] 0.22 2.44 0.87 ± 0.47 0.78 (0.52–1.12)
Uric acid [mg/L] 23.30 121.40 57.32 ± 18.19 53.9 (46.17–65.38)
FPG [g/L] 0.6 3.31 0.65 ± 0.30 0.79 (0.70–0.95) 
SD — standard deviation; IQR — interquartile range; BMI — body mass index; BP — blood pressure; LDL — low-density lipoprotein;  
HDL — high-density lipoprotein; FPG — fasting plasma glucose
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(b = 0.17, 95% CI 0.08–0.25; p < 0.0001, R2 = 0.12), 
FPG (b = 8.01, 95% CI 2.66–13.36; p = 0.004, 
R2 = 0.077) and DBP (b = 3.88, 95% CI 2.84–4.92; 
p < 0.0001, R2 = 0.34), but not with BMI (b = 0.29, 
95% CI –0.03–0.60; p = 0.073, R2 = 0.030). In the 
multivariable model, LDL-C (adjusted b = 3.27, 
95% CI 1.06–5.49; p = 0.004, R2 = 0.048), FPG 
(adjusted b = 5.40, 95% CI 1.09–9.71; p = 0.015, 
R2 = 0.035), and DBP (adjusted b = 3.49, 95% CI 
2.48–4.48; p < 0.0001, R2 = 0.275) remained as-
sociated with CVR, the coefficient of determination 
of this model being R2 = 0.426.
All the variables significant in univariable 
logistic regression analyses are presented in Ta-
ble 3. After adjustment, women not married (i.e. 
single, divorced or widowed) (adjusted odds ratio 
[aOR] 4.66, 95% CI 1.72–12.60; p = 0.002), those 
with high titers of LDL-C (≥ 1.6 g/L; aOR 5.07, 
95% CI 2.01–12.83; p = 0.001), and those with 
elevated DBP (≥ 90 mm Hg; aOR 8.10, 95% CI 
3.07–21.33; p < 0.0001) when compared with their 
counterparts, presented an increased likelihood to 
be at an advanced level of CVR in comparison to 
their current one (Table 4).
Discussion
This cross-sectional study conducted among 
108 SSA post-menopausal women revealed that 
nearly two-thirds of participants (60.2%) presented 
a moderate or high 10-year risk of CVD. Marital 
status, LDL-C, DBP and FPG may be other factors 
shaping CVR in our context. Therefore, concur-
ring Sekuri et al. [18] recommendations, strong 
interventions to significantly reduce CVR among 
post-menopausal women should be included in 
routine primary health care programs. As such, 
these women should receive educational sessions 
on healthy lifestyles, which revolve around empha-
sizing regular physical activity, avoiding or stopping 
smoking, avoiding excessive alcohol consumption, 
maintaining a normal body weight, and adopting 
a healthy diet [2, 19, 20]. Omega-3 fatty acids may 
be administered in high-risk women, as well as 
folic acid, vitamin K and vitamin D [19, 21, 22]. 
On another hand, glucose intolerance and diabetes 
should be screened, and women suffering from 
diabetes should receive adequate management to 
prevent or delay related complications.
Using the Cardiovascular Risk Score of the 
European Society of Cardiology, Sekuri et al. [18] 
assessed the CVR among 207 post-menopausal 
Turkish women from a rural setting, and found that 
86% of the women would be carrying more than 
a 5% probability of developing a CVE in the next 
10 years. These results may resemble ours despite 
the fact that different tools were used to assess 
CVR. We found indeed that 83.3% of our partici-
pants had a risk > 5%. Contrariwise, we observed 
that 24.1% of women had a high CVR, more than 
thrice equal to the 7% frequency found by Sekuri et 
al. [18]. Besides, the number of women presenting 
high titers of TC in our study (67.6%) was almost 
twice equal to the 35.3% percentage obtained by 
Sekuri et al. [18] among their Turkish women. Our 
results may reflect an unhealthy diet consumed in 
our settings made up of plenty of fats (especially 
unsaturated fatty acids), added to a lack of regular 
physical exercise as we have observed.
In fact, physical inactivity is a well-recognized 
and important contributor to coronary heart dis-
ease (CHD), especially in women [23]. Adults who 
are insufficiently physically active have a higher 
risk of all-cause mortality compared with those who 
do at least 150 min of moderate-intensity physical 
activity per week, or equivalent, as recommended 
by WHO [2]. Regular physical activity reduces the 
risk of CHD, stroke, diabetes, and breast and colon 
cancers [2]. Specifically, physical activity is associ-
ated with beneficial changes in circulating lipids and 
lipoproteins [24, 25], body weight, blood pressure, 
insulin sensitivity [26], and coagulation parameters 
[27, 28]. There is overwhelming evidence of an 
association between regular physical training and 
lowering of plasma TG, TC and LDL-C concentra-
tions, and an increase in the plasma HDL-C titers, 
hence a significant reduction in CVR [24, 29, 30]. 
Therefore, our women should be encouraged to 
practice regular physical exercise.
High levels of TG and LDL-C, and low levels of 
HDL-C are the three elements shaping atherogenic 
dyslipidemia, and are recognized as independent 
risk factors for CVD [31, 32]. We observed that 
each increase in LDL-C levels of 1 g/L may lead 
to a 3.2% increase in CVR, and women who have 
elevated titers of LDL-C (≥ 1.6 g/L) when com-
pared to their counterparts, may present a 5-fold 
increased likelihood to be at an advanced level of 
CVR in comparison to their current one. There-
fore, it can be inferred from the present study 
that reduction of CVR in post-menopausal women 
of our settings must focus on strategies to reduce 
LDL-C levels. In this regard, women should be 
educated on consumption of a healthy diet, i.e. 
consumption of a variety of fruits, vegetables, 
cereals, dairy products with low or without fat; 
consumption of fish, legumes, and proteins with 
low content of unsaturated fat (poultry, lean meat, 
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Table 3. Univariable logistic regression analyses with presentation of odds ratios and 95% confidence 
intervals (CI) for increased risk of cardiovascular disease.
Variable Odds ratio 95% CI P
Religion:
Catholic 0.83 0.41–1.68 0.612
Protestant 1
Marital status:
Married 1
Alone (single + divorced + widowed) 2.62 1.23–5.58 0.013**
Profession:
Does not earn money (housewife + retired) 1 0.47–2.10 0.997
Earn money (civil servant + trader) 1
Family history of diabetes or hypertension:
No 0.95 0.47–1.92 0.892
Yes 1
Occasional consumption of alcohol:
No 0.86 0.40–1.87 0.705
Yes 1
Regular consumption of lipids:
No 1.47 0.28–7.66 0.649
Yes 1
Regular intake of carbohydrates:
No 1.95 0.92–4.11 0.081*
Yes 1
Regular consumption of butter:
No 2.59 1.26–5.35 0.010**
Yes 1
Consumption of fruits and vegetables:
< 3 days per week 2.57 1.25–5.29 0.010**
≥ 3 days per week 1
Physical activity: 
< 3 sessions per week 0.75 0.36–1.55 0.431
≥ 3 sessions per week 1
Body mass index: 
Normal (18–24.9 kg/m2) 0.15 0.02–0.90 0.038**
Overweight (25–29.9 kg/m2) 0.50 0.13 -1.92 0.311
Obesity (30–39.9 kg/m2) 0.58 0.16–2.14 0.411
Morbid obesity (≥ 40 kg/m2) 1
Diastolic blood pressure:
< 90 mm Hg 1
≥ 90 mm Hg 6.45 2.86–14.56 < 0.0001**
Fasting blood glucose: 
< 1.26 g/L 1
≥ 1.26 g/L 20.33 2.20–187.35 0.008**
Uric acid:
< 60 mg/L 1
≥ 60 mg/L 4.54 2.10–9.81 < 0.0001**
Triglycerides: 
< 1.6 g/L 1
≥ 1.6 g/L 2.68 0.75–9.63 0.131*
LDL cholesterol:
< 1.6 g/L 1
≥ 1.6 g/L 3.94 1.87–8.29 < 0.0001**
*p < 0.20; **p < 0.05; LDL — low-density lipoprotein
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plant); restriction of consumption of unsaturated 
fat (< 10% of total calories), cholesterol (300 mg/ 
/daily), and trans-fatty acids) [2, 19, 20]. It is worth 
emphasizing, however, that diet alone may be 
unsatisfactory and should therefore be associated 
with regular physical exercise as it has been shown 
that diet restriction without exercise may appear 
inefficient [20, 33].
Diabetes is known to substantially increase 
the risk of CVD [34]. Indeed, Haffner et al. [34] 
Table 4. Multivariable logistic regression analysis with presentation of adjusted odds ratios (aOR) and 
95% confidence intervals (CI) for increased risk of cardiovascular disease.
Variable aOR 95% CI P
Marital status:
Married 1
Alone (single + divorced + widowed) 4.66 1.72–12.60 0.002*
Regular consumption of butter:
No 1.78 0.76–4.17 0.187
Yes 1
Regular intake of carbohydrates:
No 1.96 0.79–4.84 0.144
Yes 1
Consumption of fruits and vegetables:
< 3 days per week 1.01 0.42–2.34 0.980
≥ 3 days per week 1
Body mass index: 
Normal (18–24.9 kg/m2) 0.18 0.02–1.68 0.134
Overweight (25–29.9 kg/m2) 0.55 0.09–3.27 0.513
Obesity (30–39.9 kg/m2) 0.54 0.10–3.01 0.478
Morbid obesity (≥ 40 kg/m2) 1
Diastolic blood pressure:
< 90 mm Hg 1
≥ 90 mm Hg 8.10 3.07–21.33 < 0.0001*
Uric acid:
< 60 mg/L 1
≥ 60 mg/L 1.50 0.54–4.14 0.439
LDL cholesterol:
< 1.6 g/L 1
≥ 1.6 g/L 5.07 2.01–12.83 0.001*
Fasting blood glucose: 
< 1.26 g/L 1
≥ 1.26 g/L 14.60 0.80–265.87 0.070
Triglycerides: 
< 1.6 g/L 1
≥ 1.6 g/L 0.69 0.13–3.53 0.655
*p < 0.05; all variables with a p value < 0.20 in the univariable models (see Table 3) were introduced in this multivariable model:  
R2 (McFadden) = 0.286; p < 0.0001; LDL — low density lipoprotein
demonstrated that individuals with diabetes have 
a 2- to 4-fold increased risk of developing CVE than 
those of the same age and sex without diabetes. 
Furthermore, individuals with a 2-h plasma glu-
cose of 10.01–11.09 mmol/L have cardiovascular 
mortality risks similar to those with diabetes [35]. 
We found that an elevation of 1 g/L in FPG levels 
may be linked to an increase of 5.4% in CVR. We 
also observed that CVR was significantly higher 
among known diabetes patients (p < 0.0001), but 
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may be due to our dichotomizing threshold, we 
did not find any relation between CVR and FPG in 
logistic regression. It appears nonetheless of great 
importance to screen for glucose intolerance and 
diabetes in our post-menopausal women.
Recently, new factors influencing CVR have 
been delineated among post-menopausal women, 
especially sleeping disorders, depression, vitamin D 
insufficiency, rheumatoid arthritis, sexual dysfunc-
tion, stress, and psychosocial factors [36]. This 
study adds to the literature that marital status of 
the post-menopausal woman may influence her 
CVR. We found indeed that women not in couple 
(single or divorced or widowed) presented a 4.7-
-fold increased likelihood to develop CVD than 
married women. Besides, we have also noticed 
that an increment of 1 mm Hg in DBP may be ac-
companied by an increase in CVR of 3.5%, and that 
women with elevated DBP (≥ 90 mm Hg) when 
compared to those with normal DBP may have an 
8-fold increased probability to be at an advanced 
level of CVR in comparison to their current one. 
Nonetheless, more studies are needed to exten-
sively examine the contribution of marital status 
as well as DBP on post-menopausal women CVR, 
especially in our context.
Presumably, the cross-sectional design of this 
study added to its relatively small sample size hin-
dered from catching up other factors which could 
have impacted CVR in our setting. Additionally, 
in the absence of locally developed tools to assess 
CVR, we used the FRS which may lack to accurately 
assess CVR in African populations as they may 
present different patterns of CVD when compared 
with developed countries [37]. Recruitment of 
participants in a hospital setting rather than in the 
community could have perhaps led to an overestima-
tion of CVR. Nonetheless, we used strong analytical 
methods to reliably investigate our research ques-
tion. Besides and to the best of our knowledge, this 
is the first study held in Central Africa aiming at 
assessing post-menopausal women CVR.
Conclusions
This study showed that a significant number of 
post-menopausal women are at considerable risk of 
CVE in our setting. Marital status, FPG, DBP and 
LDL-C may influence these women’s CVR, hence 
inferring that changes in lifestyle could significant-
ly lessen the occurrence of CVD in this population. 
Therefore, women should be educated to adopt 
healthy lifestyles including avoidance or cessation 
of smoking, regular physical activity, maintenance 
of a normal body weight, and consumption of a diet 
containing low unsaturated fatty acids and intake of 
increased amounts of fruits and vegetables. More 
studies are needed to clarify the contribution of 
various risk factors on the occurrence of CVD in 
our context, and accurate CVR assessment tools 
urgently need to be developed locally.
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